blog posts Hergenrother named a 2023 National Cancer Institute Outstanding Investigator Jan 16, 2024 2:30 pm by Jonathan KingExcellence Share on Facebook Tweet Email Images Paul Hergenrother’s lab has discovered multiple new anticancer compounds, including PAC-1, which recently completed a Phase 1 clinical trial in late-stage cancer patients. Share on Facebook Tweet Email